Unknown

Dataset Information

0

Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye.


ABSTRACT: LFA-1/ICAM-1 interaction is essential in support of inflammatory and specific T-cell regulated immune responses by mediating cell adhesion, leukocyte extravasation, migration, antigen presentation, formation of immunological synapse, and augmentation of T-cell receptor signaling. The increase of ICAM-1 expression levels in conjunctival epithelial cells and acinar cells was observed in animal models and patients diagnosed with dry eye. Therefore, it has been hypothesized that small molecule LFA-1/ICAM-1 antagonists could be an effective topical treatment for dry eye. In this letter, we describe the discovery of a potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonist (SAR 1118) and its development as an ophthalmic solution for treating dry eye.

SUBMITTER: Zhong M 

PROVIDER: S-EPMC4025648 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


LFA-1/ICAM-1 interaction is essential in support of inflammatory and specific T-cell regulated immune responses by mediating cell adhesion, leukocyte extravasation, migration, antigen presentation, formation of immunological synapse, and augmentation of T-cell receptor signaling. The increase of ICAM-1 expression levels in conjunctival epithelial cells and acinar cells was observed in animal models and patients diagnosed with dry eye. Therefore, it has been hypothesized that small molecule LFA-1  ...[more]

Similar Datasets

| S-EPMC5240001 | biostudies-literature
| S-EPMC9999266 | biostudies-literature
| S-EPMC6719011 | biostudies-literature
| S-EPMC6625033 | biostudies-literature
| S-EPMC4859202 | biostudies-literature
| S-EPMC7140734 | biostudies-literature
| S-EPMC5491700 | biostudies-other
| S-EPMC6219330 | biostudies-literature
| S-EPMC10838901 | biostudies-literature
| S-EPMC8498931 | biostudies-literature